Corcept targets $3B-$5B in Cushing’s revenue in 2030 as it awaits December 17 relacorilant FDA decision
This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:
Read full article at Seeking Alpha
Related stories
Tiendas 3B signals no change in 590 to 630 store-opening guidance while outlining more transportation optimization in 2027
Seeking Alpha · 8 min ago
Tennessee embarrassed Alabama. CFP committee embarrassed itself
Yahoo Sports · 14 min ago
How Oregon State turned a raw athlete into a starting linebacker
Yahoo Sports · 15 min ago
Midterm elections could jolt stocks if Democrats sweep Congress
CNBC · 15 min ago
Democrats flip first Senate seat as Cooper wins in North Carolina
Seeking Alpha · 16 min ago
Miami tops 1st CFP rankings as date with No. 11 Notre Dame looms
ESPN · 17 min ago